Skip to main content

Basic Science Representative on PRS

October 4, 2019

MIRI PI Perrie O’Tierney-Ginn, PhD, was elected to the Perinatal Research Society (PRS) council as their Basic Science representative for 2019-2021.

Perrie O’Tierney-Ginn, PhD

MIRI Principal Investigator Perrie O’Tierney-Ginn, PhD, was elected to the Perinatal Research Society (PRS) council as their Basic Science representative for 2019-2021. As the mission statement of PRS notes, it was “established in 1969 to foster scientific interchange and communication among neonatologists, obstetricians and basic scientists whose research interests were in the area of perinatal medicine and developmental biology.

The PRS is unique in that they target their membership to equally balance the specialties represented in them: one-third neonatologists; one-third obstetricians; and one-third basic scientists. “This focus on the balance and interaction between these fields makes this a natural scientific home for me, as a Mother Infant Research Institute investigator, and I feel quite honored to be elected to represent basic scientists on the PRS Council,” Dr. O’Tierney-Ginn said. Her overall research interest is to understand the effect of the maternal nutritional environment (metabolism, diet, body composition) on placental function and fetal nutrient delivery and growth.

Drs. Thaler and Kimmelstiel
Articles
Tufts Medicine Team Pioneers New Patent Foramen Ovale Closure Device
December 11, 2025
Tufts Medical Center becomes the first site to evaluate the new P3 Occluder System for patent foramen ovale closure, advancing stroke-prevention research.
Jonathan Davis, MD
Articles
Tufts Medicine physician helps lead national effort to accelerate pediatric medical device innovation
December 4, 2025
A Tufts Medicine neonatologist is helping chart a new national path to improve how medical devices are developed for children—a long-standing gap in U.S. healthcare.
Articles
Tufts Medicine-led Research: Rapid Genome Sequencing Can Save $160K per Patient
November 17, 2025
Early rapid genome sequencing can save $160K per patient, new Tufts Medicine-led study shows

Be among the first to know

Enjoy the latest health updates from Tufts Medicine by signing up for our e-newsletter today.

Jump back to top